Sign in

CIK 0001600620

  • Large accelerated filer

Aurinia Pharmaceuticals Inc.

Sign in to watch
Ticker
AUPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981231763
Phone
+1 250-744-2487
Business address
#140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$379,943
in 2 filings

Net −$379,943. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Robertson Stephen P. −$380K Chief Legal Officer sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2024-05-21 Billen Daniel Director Sale −5,252 $5.74 $30K 28,141
2023-05-23 Billen Daniel Director Sale −4,650 $11.26 $52K 33,393
2023-05-19 Billen Daniel Director Grant or award +9,310 38,043
2023-05-19 Billen Daniel Director Grant or award · Stock Option (right to buy) +15,234 15,234
2023-05-18 Billen Daniel Director Exercise or conversion +8,733 28,733
2023-05-18 Billen Daniel Director Exercise or conversion · Restricted Stock Units −8,733 0
2022-05-18 Billen Daniel Director Grant or award · Restricted Stock Unit +8,733 8,733
2022-05-18 Billen Daniel Director Grant or award · Stock Option (right to buy) +14,612 14,612
2021-06-14 Billen Daniel Director Grant or award · Stock Option (right to buy) +31,347 31,347

Page 1 of 1 · 9 trades